Sunday, February 8, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Challenges and Opportunities for CPS Technologies Corporation

Elaine Mendonca by Elaine Mendonca
March 8, 2024
in Breaking News
0
The Rise of Strategic Partnerships in Life Sciences: Trends Shaping the Future of Healthcare Innovation
0
SHARES
6
VIEWS
Share on FacebookShare on Twitter

On March 7, 2024, CPS Technologies Corporation disclosed a drop in their Q4 EPS results compared to the previous year. This led to a 4.5% decrease in their stock price.

Despite being recognized for their innovative materials manufacturing business, with products even on the international space station, CPS Technologies is encountering obstacles due to their small size, limited profitability, and high valuation in relation to their revenue.

The company recently landed a defense contract to supply armor panels to the U.S. Navy, which caused a significant surge in their market capitalization. However, this sudden increase has raised concerns about CPS Technologies’ overall valuation and profitability moving forward.

CPS Technologies Corporation (CPSH) Stock Price Plummets 21.23% on March 7, 2024: What Investors Need to Know

On March 7, 2024, CPS Technologies Corporation (CPSH) experienced a significant drop in its stock price, closing at $1.99. This marked a decrease of $0.53, or 21.23%, from the previous market close. Despite the steep decline during regular trading hours, CPSH saw a slight uptick of $0.02 in after-hours trading. It is important for investors to closely monitor the stock’s performance and any relevant news or developments that may impact its price movement. Factors such as market trends, company announcements, and industry news can all influence the direction of CPSH’s stock price.

CPSH Stock Performance: Revenue Up, Net Income Down – March 7, 2024 Update

On March 7, 2024, CPSH stock experienced mixed performances based on the latest financial data released by the company. The total revenue for CPSH stood at $26.59 million for the past year, showing an 18.43% increase compared to the previous year. However, the total revenue for the third quarter of the year was $6.29 million, indicating a 15.27% decrease compared to the previous quarter.

The net income for CPSH was reported at $2.13 million for the past year, which represented a 33.72% decrease compared to the previous year. The net income for the third quarter of the year was $171.08 thousand, showing a significant 71.51% decrease compared to the previous quarter.

Furthermore, the earnings per share (EPS) for CPSH were $0.15 for the past year, reflecting a 34.12% decrease compared to the previous year. The EPS for the third quarter of the year was $0.01, indicating a substantial 71.53% decrease compared to the previous quarter.

Overall, the financial performance of CPSH on March 7, 2024, showed a mixed picture. Investors and analysts will closely monitor future financial reports from CPSH to assess the company’s performance and outlook in the market.

Tags: CPSH
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Pharmaceutical Market Capitalization

MindMeds MM120 Program Receives FDA Breakthrough Therapy Designation and Shows Promising Results

Fitness and app

Pelotons CFO Optimistic About Financial Outlook and Shift to Positive Cash Flow

Finances-and-tech

Analyzing Recent Options Trading Trends in Target Stock

Recommended

UBS Stock

UBS Share Buyback Fails to Impress Amid Regulatory Fears

3 months ago
IBM Stock

IBM’s UFC Partnership Showcases AI Capabilities in Live Sports

3 months ago
ImmunityBio Stock

ImmunityBio Shares Gain Momentum on Strong Revenue and Regulatory Progress

6 days ago
BioNTech Stock

BioNTech’s Billion-Euro Forecast Shift Stuns Market

3 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Design Therapeutics Approaches Key Clinical Milestones with Ample Funding

Sanofi Completes Vigil Neuroscience Acquisition, Eyes Alzheimer’s Therapy

Repay Holdings: Annual Report to Test Strategic Refinancing Success

Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

Graftech Shares Plunge on Bleak Quarterly Results

Potbelly Accelerates Northeast Growth with New Jersey Franchise Push

Trending

Rock Tech Lithium Stock
Analysis

Rock Tech Lithium: Investors Await the Final Go-Ahead

by Jackson Burston
February 8, 2026
0

Investors in Rock Tech Lithium are in a holding pattern, with all eyes fixed on a pending...

Puma Biotechnology Stock

Puma Biotechnology Sets Date for Full-Year Financial Disclosure

February 8, 2026
Quanterix Stock

Quanterix Seeks FDA Clearance for Groundbreaking Alzheimer’s Blood Test

February 8, 2026
Design Therapeutics Stock

Design Therapeutics Approaches Key Clinical Milestones with Ample Funding

February 7, 2026
Vigil Neuroscience Stock

Sanofi Completes Vigil Neuroscience Acquisition, Eyes Alzheimer’s Therapy

February 7, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Rock Tech Lithium: Investors Await the Final Go-Ahead
  • Puma Biotechnology Sets Date for Full-Year Financial Disclosure
  • Quanterix Seeks FDA Clearance for Groundbreaking Alzheimer’s Blood Test

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com